GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
7.14
-0.55 (-7.15%)
At close: Oct 14, 2025, 4:00 PM EDT
7.55
+0.41 (5.74%)
Pre-market: Oct 15, 2025, 8:07 AM EDT
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $6.42 million as of October 15, 2025. Its market cap has decreased by -51.96% in one year.
Market Cap
6.42M
Enterprise Value
-2.87M
1-Year Change
-51.96%
Ranking
Category
Stock Price
$7.14
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $6.42M, a decrease of -81.18%. That is a compound annual growth rate of -12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 6.42M | 7.26% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |